The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Search the full ICD-10 catalog by:
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.
The 2022 edition of ICD-10-CM Z01.02 became effective on October 1, 2021 .
Z01.02 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease. Type 1 Excludes. encounter for diagnostic examination-code to sign or symptom. Encounter for screening for other diseases and disorders.
The 2021 edition of ICD-10-CM Z13.5 became effective on October 1, 2020.
The term 'low vision' in category H54 comprises categories 1 and 2 of the table, the term 'blindness' categories 3, 4 and 5, and the term 'unqualified visual loss' category 9.
Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., macular degeneration; retinitis pigmentosa; diabetic retinopathy, etc.). Visual loss: objective loss of visual acuity during a finite period attributable to an underlying disease.
History of vision problem. Personal condition of sight problem. Visual impairment. Clinical Information. Limitation in visual functions. Reduced ability to perceive visual stimuli. Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility.
The 2022 edition of ICD-10-CM H54.7 became effective on October 1, 2021.
Visual loss: objective loss of visual acuity during a finite period attributable to an underlying disease.